Fortis Therapeutics Llp - Company Profile

It is a business services limited liability partnership based in Dibrugarh, Assam, India, established in 2024.
2024 Dibrugarh, Assam, India Active
Last Updated:
Access Report
About Fortis Therapeutics Llp

Fortis Therapeutics Llp, a active limited liability partnership, was established on 03 February 2024 in Dibrugarh, Assam, India. it holds LLPIN: ACF-3008. Registered under ROC Roc Guwahati. It has total obligation of contribution of ₹60.00 K .

Formerly known as Fortis Therapeutics Llp. Its leadership includes Arvind Varma (Designated Partner), Rohit Kumar Killa (Designated Partner). Past directors included Arvind Varma. It holds ₹3.50 M open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2025. It is based at C/O Mridu Paban Mahanta J. Das Line (Jogesh Das Path, Khaliamari), Dibrugarh, Assam, 786001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ACF-3008

  • Incorporation Date

    03 February 2024

  • Total Obligation of Contribution

    ₹60.00 K

  • ROC Code

    Roc Guwahati

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 60.00 K
  • Company Age 2 Year, 10 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 3.50 M
Company report

Fortis Therapeutics Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Fortis Therapeutics Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Fortis Therapeutics Llp?
Current Designated Partners
Name Designation Appointment Date Status
Arvind Varma Designated Partner 08 May 2025 Current
Rohit Kumar Killa Designated Partner 03 Feb 2024 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner 07 May 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Fortis Therapeutics Llp.
Fortis Therapeutics Llp revenue growth over time
Fortis Therapeutics Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Fortis Therapeutics Llp?

Unlock access to Fortis Therapeutics Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Canara Bank : 0.35 Cr
Latest Charge Details
Date Lender Amount Status
20 Jun 2025 Canara Bank ₹3.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Fortis Therapeutics Llp?

Unlock and access historical data on people associated with Fortis Therapeutics Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Fortis Therapeutics Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortis Therapeutics Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Fortis Therapeutics Llp
Recent Activity within the Organization
  • Charges

    A charge with Canara Bank amounted to Rs. 3,500,000.00 with Charge ID 101133771 was registered on 20 Jun 2025. was recorded as a recent event.

  • Director Appointment

    The activity Arvind Varma was appointed as a Designated Partner was appointed as a Designated Partner on 08 May 2025 & has been associated with this company since 9 months 7 days . was completed.

  • Annual General Meeting

    Progress on Fortis Therapeutics Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    The activity Fortis Therapeutics Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Guwahati. was completed.

  • Director Appointment

    Progress on Rohit Kumar Killa was appointed as a Designated Partner was appointed as a Designated Partner on 03 Feb 2024 & has been associated with this company since 2 years 10 days . was documented.

  • LLP Incorporation

    Progress on Fortis Therapeutics Llp was registered on 03 Feb 2024 with Roc Guwahati & aged 2 years 10 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Fortis Therapeutics Llp?

The LLPIN of Fortis Therapeutics Llp is ACF-3008.

Where is Fortis Therapeutics Llp headquartered?

Fortis Therapeutics Llp is headquartered at C/O Mridu Paban Mahanta J. Das Line (Jogesh Das Path, Khaliamari), Dibrugarh, Assam, 786001.

When was Fortis Therapeutics Llp incorporated?

Fortis Therapeutics Llp was incorporated on 03 February 2024.

Who are the current directors of Fortis Therapeutics Llp?

The current directors of Fortis Therapeutics Llp are

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available